Additionally, we have shown BAR502 (41, 42), a semisynthetic bile alcohol steroidal agonist of FXR and GPBAR1, as a potential hLIFR antagonist acting as a tumour suppressor and reverting proliferation and EMT process in a LIFR-dependent manner. This evidence concerns the gene NR1H4 and neoplasm.